Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Idriss Amine Lahlou"'
Autor:
Sara El Zaitouni PhD, Abdelilah Laraqui PhD, Meriem Ghaouti MD, Asmae Benzekri MD, Fouad Kettani MD, Youssra Boustany PhD, Soukaina Benmokhtar PhD, Hafsa Lamrani Alaoui MD, Hicham El Annaz MD, Rachid Abi MD, Mohamed Rida Tagajdid MD, Safae El Kochri MD, Bouchra El Mchichi PhD, El Arbi Bouaiti MD, Idriss Amine Lahlou MD, Rabii Ameziane El Hassani PhD, Khalid Ennibi MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 23 (2024)
Objectives We retrospectively analyzed the next-generation sequencing (NGS) results from diagnosed NSCLC patients to identify and compare genomic alterations of NSCLC between Moroccan patients and the Cancer Genome Atlas (TCGA). We also aimed to inve
Externí odkaz:
https://doaj.org/article/d7d000f13cfe4db69757536cb7dd46d2
Autor:
Sara El Zaitouni, Abdelilah Laraqui, Meriem Ghaouti, Asmae Benzekri, Fouad Kettani, Tahar Bajjou, Yassine Sekhsokh, Soukaina Benmokhtar, Meryem Jafari, Walid Baba, Mohamed Oukabli, Hicham El Annaz, Rachid Abi, Mohamed Rida Tagajdid, Safae El Kochri, Idriss Amine Lahlou, Rabii Ameziane El Hassani, Khalid Ennibi
Publikováno v:
Cancer Control, Vol 31 (2024)
Objectives The present study aimed to evaluate the frequencies of KRAS , NRAS, and BRAF mutations and their possible associations with clinicopathological features in 249 Moroccan patients with colorectal cancer (CRC). Methods A retrospective investi
Externí odkaz:
https://doaj.org/article/1060de11b6c04f15b48008e30113c90f
Autor:
Soukaina Benmokhtar, Abdelilah Laraqui, Farida Hilali, Tahar Bajjou, Sara El Zaitouni, Meryem Jafari, Walid Baba, Hicham Elannaz, Idriss Amine Lahlou, Chahdi Hafsa, Mohamed Oukabli, Tarik Mahfoud, Rachid Tanz, Mohamed Ichou, Khaled Ennibi, Nadia Dakka, Yassine Sekhsokh
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 18 (2024)
Background: This review article aims to investigate the prevalence and spectrum of rat sarcoma (RAS) and V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) mutations, and their connection with geographical location, clinicopathological features, an
Externí odkaz:
https://doaj.org/article/ec59c418fefc473583b254fc4e749f89
Autor:
Meryem Jafari, Abdelilah Laraqui, Walid Baba, Soukaina Benmokhtar, Sara El Zaitouni, Abdelmounaim Ait Ali, Ahmed Bounaim, Mountassir Moujahid, Rachid Tanz, Tarik Mahfoud, Yassir Sbitti, Hicham El Annaz, Rachid Abi, Mohamed Rida Tagajdid, Safae El Kochri, Idriss Amine Lahlou, Houda El Hsaini, Lamiae Belayachi, Abdelaziz Benjouad, Mohammed Ichou, Amina En-Nya, Khalid Ennibi
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Our review discuss (i) the findings from analyzed data that have examined KRAS, NRAS and BRAF mutations in patients with colorectal cancer (CRC) in North Africa and to compare its prevalence with that shown in other populations an
Externí odkaz:
https://doaj.org/article/23980ed495e542b2820343bd6e3d03d0
Autor:
Soukaina, Benmokhtar, Abdelilah, Laraqui, Fatima, El Boukhrissi, Farida, Hilali, Tahar, Bajjou, Meryem, Jafari, Sara, El Zaitouni, Walid, Baba, Bouchra, El Mchichi, Hicham, Elannaz, Idriss Amine, Lahlou, Hafsa, Chahdi, Mohamed, Oukabli, Tarik, Mahfoud, Rachid, Tanz, Mohamed, Ichou, Khaled, Ennibi, Nadia, Dakka, Yassine, Sekhsokh
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 23:3725-3733
Mutations in RAS (KRAS, NRAS) and BRAF genes are the main biomarker predicting response to anti-EGFR monoclonal antibodies in targeted therapy in colorectal cancer (CRC).Our study aims to evaluate the frequencies of KRAS, NRAS and BRAF mutations and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed2423a01f961234e33c671b9edfc843
https://doi.org/10.31557/apjcp.2022.23.11.3725
https://doi.org/10.31557/apjcp.2022.23.11.3725
Autor:
Sara El zaitouni, Abdelilah Laraqui, Meriem Ghaouti, Asmae Benzekri, Fouad Kettani, Hicham El Annaz, Rachid Abi, Mohamed Rida Tagajdid, Safae El Kochri, Idriss Amine Lahlou, Rabii Ameziane El Hassani, Khalid Ennibi
Publikováno v:
Journal of Clinical Oncology. 41:216-216
216 Background: Morocco has the highest cancer mortality rate in MENA Countries. Colorectal cancer (CRC) is classified as the first digestive cancer and remains a burden in Morocco. According to the data on GLOBOCAN 2020, there were 4324 new CRC pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6edc127d2c5ba43c99c8421ba43102f
https://doi.org/10.1200/jco.2023.41.4_suppl.216
https://doi.org/10.1200/jco.2023.41.4_suppl.216